The origin and evolution of mutations in acute myeloid leukemia

Welch, John S., Ley, Timothy J., Link, Daniel C., Miller, Christopher A., Larson, David E., Koboldt, Daniel C., Wartman, Lukas D., Lamprecht, Tamara L. +46 more·2012·Cell

DOI 10.1016/j.cell.2012.06.023

Cited by (1,001)

Items 501–600 of 1,001

DNA-damage response in hematopoietic stem cells: an evolutionary trade-off between blood regeneration and leukemia suppression
Shahar Biechonski, Muhammad Yassin, Michael Milyavsky · 2017 · Carcinogenesis
Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy
Meghali Goswami, Gabrielle T. Prince, Angélique Biancotto, Susan L. Moir, Lela Kardava, Brian H. Santich, Foo Cheung, Yuri Kotliarov, Jinguo Chen, Rongye Shi et al. · 2017 · Journal of Translational Medicine
Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia
Jacqueline Lehmann‐Che, Cécile Bally, Éric Letouzé, Caroline Berthier, Hao Yuan, Florence Jollivet, Lionel Adès, Bruno Cassinat, Pierre Hirsch, Arnaud Pigneux et al. · 2018 · Nature Communications
Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia
Concetta Di Natale, Sara La Manna, Anna Maria Malfitano, Sarah Di Somma, Daniele Florio, Pasqualina Liana Scognamiglio, Ettore Novellino, Paolo A. Netti, Daniela Marasco · 2019 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Most gene fusions in cancer are stochastic events
Bertil Johansson, Fredrik Mertens, Tommy Schyman, Jonas Björk, Nils Mandahl, Felix Mitelman · 2019 · Genes Chromosomes and Cancer
Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome
Amanda M. Smith, Taylor A. LaValle, Marwan S. Shinawi, Sai Mukund Ramakrishnan, Haley Abel, Cheryl A. Hill, Nicole M. Kirkland, Michael P. Rettig, Nichole Helton, Sharon E. Heath et al. · 2021 · Nature Communications
Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes
Yan Ping Guo, Amma Bosompem, Sanjay Ram Mohan, Begüm Erdoğan, Fei Ye, Kasey C. Vickers, Quanhu Sheng, Shilin Zhao, Chung-I Li, Pei-Fang Su et al. · 2015 · BMC Genomics
Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
Christopher Ramin Cogle, Bart Lee Scott, Thomas E. Boyd, Guillermo Garcia‐Manero · 2015 · The Oncologist
RUNX1 cooperates with FLT3-ITD to induce leukemia
Kira Behrens, Katrin Maul, Nilgün Solak Tekin, Neele Kriebitzsch, Daniela Indenbirken, Vladimir Prassolov, Ursula Müller, Hubert L. Serve, Jörg Cammenga, Carol Stocking · 2017 · The Journal of Experimental Medicine
Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia
Pierre Hirsch, Ruoping Tang, Nasséra Abermil, Pascale Flandrin‐Gresta, Hannah Moatti, Fabrizia Favale, Ludovic Suner, Florence Lorre, Christophe Marzac, Fanny Fava et al. · 2017 · Haematologica
Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse
Brian L. Parkin, Angelina I. Londoño-Joshi, Qing Kang, Muneesh Tewari, Andrew D. Rhim, Sami N. Malek · 2017 · Journal of Clinical Investigation
Clonal Hematopoiesis and Its Impact on Cardiovascular Disease
Soichi Sano, Ying Wang, Kenneth Walsh · 2018 · Circulation Journal
The Dynamics of Somatic Mutagenesis During Life in Humans
Freek Manders, Ruben van Boxtel, Sjors Middelkamp · 2021 · Frontiers in Aging
Stem cell mutations, associated cancer risk, and consequences for regenerative medicine
Lucca L. M. Derks, Ruben van Boxtel · 2023 · Cell stem cell
Cost-Effective and Scalable Clonal Hematopoiesis Assay Provides Insight into Clonal Dynamics
Taralynn Mack, Caitlyn Vlasschaert, Kelly von Beck, Alexander James Silver, Jonathan Brett Heimlich, Hannah M. Poisner, Henry Robert Condon, Jessica Ulloa, Andrew L. Sochacki, Travis P. Spaulding et al. · 2024 · Journal of Molecular Diagnostics
Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes
Austin Gladston Kulasekararaj, Azim M. Mohamedali, Ghulam Jeelani Mufti · 2013 · British Journal of Haematology
Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia
Elizabeth K. Engle, D A C Fisher, C A Miller, Michael D. McLellan, Robert S. Fulton, D M Moore, Richard K. Wilson, Timothy James Ley, Stephen T. Oh · 2014 · Leukemia
Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia
Nana Ping, Aining Sun, Yiting Song, Q Wang, J Yin, W Cheng, Yihan Xu, Lu Wen, H Yao, Liyuan Ma et al. · 2016 · Leukemia
PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL
Alessandra di Masi, Domenica Cilli, Francesco Berardinelli, A Talarico, Isabella Pallavicini, Rosa Pennisi, Stefano Leone, Antonio Antoccia, Nélida I. Noguera, Francesco Lo‐Coco et al. · 2016 · Cell Death and Disease
Changing mutational and adaptive landscapes and the genesis of cancer
L. Alexander Liggett, James V. DeGregori · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Action at a Distance: Allostery and the Development of Drugs to Target Cancer Cell Metabolism
Byron DeLaBarre, Jonathan Hurov, Giovanni Cianchetta, Stuart Murray, Lenny Dang · 2014 · Chemistry & Biology
Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML
Catherine E. Forristal, Anna L Brown, Falak Helwani, Ingrid G. Winkler, Bianca Nowlan, Valérie Barbier, Jason A. Powell, Grant A. Engler, Sonya M. Diakiw, Andrew C.W. Zannettino et al. · 2015 · Leukemia
Notch1-induced T cell leukemia can be potentiated by microenvironmental cues in the spleen
Shihui Ma, Yingxu Shi, Yakun Pang, Fang Dong, Hui Cheng, Sha Hao, Jing Xu, Xiaofan Zhu, Weiping Yuan, Tao Cheng et al. · 2014 · Journal of Hematology & Oncology
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
Ciprian Tomuleasa, Bobe Petrushev, Sanda Boca, Timea Nagy-Simon, Cristian Berce, Ioana C. Frinc, Delia Monica Dima, Sonia Emilia Selicean, Grigore Gafencu, Alina Tănase et al. · 2016 · International Journal of Nanomedicine
Mechanisms of leukemic transformation in congenital neutropenia
Daniel C. Link · 2018 · Current Opinion in Hematology
Clonal hematopoiesis: Pre-cancer PLUS
Alexander J. Silver, Siddhartha Jaiswal · 2019 · Advances in cancer research
FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias
Cécile Esnault, Ramy Rahmé, Kim L. Rice, Caroline Berthier, Coline M Gaillard, Samuel Quentin, Anne-Lise Maubert, Scott C. Kogan, Hugues de Thé · 2019 · Blood
Somatic Variants: New Kids on the Block in Human Immunogenetics
Lies Van Horebeek, Bénédicte Dubois, An Goris · 2019 · Trends in Genetics
SMC1B is present in mammalian somatic cells and interacts with mitotic cohesin proteins
Linda Mannini, Francesco Cucco, Valentina Quarantotti, Clelia Amato, Mara Tinti, Luigi Tana, Annalisa Frattini, Domenico Delia, Ian D. Krantz, Rolf Jessberger et al. · 2015 · Scientific Reports
Structural variation discovery in the cancer genome using next generation sequencing: Computational solutions and perspectives
Biao Liu, Jeffrey M. Conroy, Carl D. Morrison, Adekunle Odunsi, Maochun Qin, Lei Wei, Donald L. Trump, Candace S. Johnson, Song Liu, Jianmin Wang · 2015 · Oncotarget
Genomic Sequencing for Cancer Diagnosis and Therapy
Linghua Wang, David A. Wheeler · 2013 · Annual Review of Medicine
The Future of Targeting FLT3 Activation in AML
Mark B. Leick, Mark J. Levis · 2017 · Current Hematologic Malignancy Reports
A brief, but comprehensive, guide to clonal evolution in aplastic anemia
Daria V. Babushok · 2018 · Hematology
Oncogenic Deregulation of Cell Adhesion Molecules in Leukemia
Roland Windisch, Nina Pirschtat, Christian Kellner, Linping Chen-Wichmann, Jörn Lausen, Andreas Humpe, Daniela S. Krause, Christian Werner Wichmann · 2019 · Cancers
What To Tell Your Patient With Clonal Hematopoiesis And Why: Insights From Two Specialized Clinics
David P. Steensma, Kelly L. Bolton · 2020 · Blood
FLT3 Tyrosine Kinase Inhibition as a Paradigm for Targeted Drug Development in Acute Myeloid Leukemia
Michael Richard Grunwald, Mark J. Levis · 2015 · Seminars in Hematology
Cancer Is to Embryology as Mutation Is to Genetics: Hypothesis of the Cancer as Embryological Phenomenon
Jaime Cofré, Eliana S. F. W. Abdelhay · 2017 · The Scientific World JOURNAL
Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival
Wu Zhang, Chen Zhao, Junmei Zhao, Yongmei Zhu, Xiangqin Weng, Qiusheng Chen, Huiping Sun, Jian‐Qing Mi, Junmin Li, Jiang Zhu et al. · 2018 · Theranostics
Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia
Cristina Panuzzo, Elisabetta Signorino, Chiara Calabrese, Muhammad Shahzad Ali, Jessica Petiti, Enrico Bracco, Daniela Cilloni · 2020 · Journal of Clinical Medicine
Lymphohematopoietic cancers induced by chemicals and other agents and their implications for risk evaluation: An overview
David A. Eastmond, Nagalakshmi Keshava, Babasaheb R. Sonawane · 2014 · Mutation Research/Reviews in Mutation Research
Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients
Yinjun Lou, Yafang Ma, Jianai Sun, Xiujin Ye, Hanzhang Pan, Yungui Wang, Wenbin Qian, Haitao Meng, Wenyuan Mai, Jingsong He et al. · 2015 · Annals of Hematology
Etiology and pathogenesis of the cohesinopathies
Musinu Zakari, Kobe Chi Yung Yuen, Jennifer L. Gerton · 2015 · Wiley Interdisciplinary Reviews Developmental Biology
CTCF, cohesin, and histone variants: connecting the genome
Jean‐François Millau, Luc R. Gaudreau · 2011 · Biochemistry and Cell Biology
Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia
Yan Li, Qingyu Xu, Na Lv, Lili Wang, Hongmei Zhao, Xiuli Wang, Jing Guo, Chongjian Chen, Yonghui Li, Li Yu · 2017 · Journal of Hematology & Oncology
Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia
Yoko Tabe, Agostino Tafuri, Kazumasa Sekihara, Haeun Yang, Marina Y Konopleva · 2017 · Expert Opinion on Therapeutic Targets
Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
Thomas Mercher, Juerg Schwaller · 2019 · Frontiers in Pediatrics
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection
Francisco Caiado, Diogo Maia-Silva, Carolina Jardim, Nina Schmolka, Tânia Carvalho, Cláudia Reforço, Rita Faria, Branka Kolundžija, André E. S. Simões, Tuncay Baubec et al. · 2019 · Nature Communications
Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis
Xiaotian Zhang, Xinyu Wang, Xue Qing David Wang, Jianzhong Su, Nagireddy Putluri, Ting Zhou, Ying Qu, Mira Jeong, Anna G. Guzman, Carina Rosas et al. · 2020 · Blood
Fanconi anemia and the underlying causes of genomic instability
Julie Rageul, Hyungjin Kim · 2020 · Environmental and Molecular Mutagenesis
Clonal hematopoiesis: Molecular and clinical implications
Yael N. Kusne, Zhuoer Xie, Mrinal M. Patnaik · 2022 · Leukemia Research
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms
Spinner, Michael A., Aleshin, Alexey, Santaguida, Marianne T., Schaffert, Steven A., Zehnder, James L., Patterson, A. Scott, Gekas, Christos, Heiser, Diane, Greenberg, Peter L. · 2020 · Blood Advances
Persistence of Cisplatin-Induced Mutagenicity in Hematopoietic Stem Cells: Implications for Secondary Cancer Risk Following Chemotherapy
Stephen D. Dertinger, Svetlana L. Avlasevich, Dorothea K. Torous, Jeffrey C. Bemis, Souk Phonethepswath, Carson Labash, Kristine Carlson, Jared A. Mereness, John Cottom, James Palis et al. · 2014 · Toxicological Sciences
Hypermutable DNA chronicles the evolution of human colon cancer
Kamila Naxerova, Elena F. Brachtel, Jesse J. Salk, Aaron M. Seese, Karen A. Power, Bardia Abbasi, Matija Snuderl, Sarah Chiang, Simon Kasif, Rakesh K. Jain · 2014 · Proceedings of the National Academy of Sciences
Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses
Vibe Skov · 2020 · Cancers
Evolving insights: how DNA repair pathways impact cancer evolution
Jiadong Zhou, Xiao Albert Zhou, Ning Zhang, Jiadong Wang · 2020 · Cancer Biology and Medicine
Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia
Ewa M. Kościuczuk, Diana Saleiro, Leonidas C. Platanias · 2016 · Cytokine
Unveiling the metal mutation nexus: Exploring the genomic impacts of heavy metal exposure in lung adenocarcinoma and colorectal cancer
Meng‐Yuan Liu, Yuting Hong, Xiaohong Duan, Qiming Zhou, Jing Chen, Siyao Liu, Junyan Su, Han Li, Jiali Zhang, Beifang Niu · 2023 · Journal of Hazardous Materials
Stem cell origin of myelodysplastic syndromes
Harold Kunal Elias, Carolina Schinke, Sanchari Bhattacharyya, Britta Will, Amit K. Verma, Ulrich G. Steidl · 2013 · Oncogene
Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia
Tilmann Bochtler, Stefan Fröhling, A. Krämer · 2015 · Leukemia
AMG 925 Is a Dual FLT3/CDK4 Inhibitor with the Potential to Overcome FLT3 Inhibitor Resistance in Acute Myeloid Leukemia
Cong Li, Liqin Liu, Lingming Liang, Zhen Xia, Zhihong Li, Xianghong Wang, Lawrence R. McGee, Katie Newhall, Angus M. Sinclair, Alexander Kamb et al. · 2014 · Molecular Cancer Therapeutics
Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia
Amanda Przespolewski, Eunice S. Wang · 2016 · Expert Opinion on Investigational Drugs
FLT3 inhibitors: clinical potential in acute myeloid leukemia
Marie‐Anne Hospital, Alexa Samantha Green, Thiago Trovati Maciel, Ivan Cruz Moura, Anskar Y.H. Leung, Didier Bouscary, Jérôme Tamburini · 2017 · OncoTargets and Therapy
Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia
Myint Myat Khine Aung, Megan L. Mills, Joana Bittencourt‐Silvestre, Karen Keeshan · 2021 · Molecular Oncology
The Mutagenic Impact of Environmental Exposures in Human Cells and Cancer: Imprints Through Time
Axel Rosendahl Huber, Arne van Hoeck, Ruben van Boxtel · 2021 · Frontiers in Genetics
Expression profiling of leukemia patients: Key lessons and future directions
Velizar Stefanov Shivarov, Lars Bullinger · 2014 · Experimental Hematology
Cohesin and CTCF differentially regulate spatiotemporal runx1 expression during zebrafish development
Judith Marsman, Adam C. O’Neill, Betty Kao, Jenny M. Rhodes, Michael Meier, Jisha Antony, Maren Mönnich, Julia A. Horsfield · 2013 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
DNA methylation in normal and malignant hematopoiesis
Hamza Celik, Ashley C. Kramer, Grant Anthony Challen · 2016 · International Journal of Hematology
Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation
Marlise Rachael Luskin, Martin P Carroll, David B. Lieberman, Jennifer J. D. Morrissette, Jianhua Zhao, Lisa M. Crisalli, David B. Roth, Selina M. Luger, David Porter, Ran Reshef · 2016 · Transplantation and Cellular Therapy
STAG2 loss-of-function affects short-range genomic contacts and modulates the basal-luminal transcriptional program of bladder cancer cells
Laia Richart, Eleonora Lapi, Véra Pancaldi, Mirabai Cuenca-Ardura, Enrique Carrillo de Santa Pau, Miguel Madrid-Mencía, Hélène Neyret‐Kahn, François Radvanyi, Juan Antonio Rodríguez, Yasmina Cuartero et al. · 2021 · Nucleic Acids Research
Prolonged persistence of mutagenic DNA lesions in somatic cells
Michael Spencer Chapman, Emily Mitchell, Kenichi Yoshida, Nicholas Williams, Margarete A. Fabre, Anna Maria Ranzoni, Philip S. Robinson, Lori D. Kregar, Christian Matthias Wilk, Steffen Boettcher et al. · 2025 · Nature
Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability
Anna C. Salzberg, Abigail Harris‐Becker, Evgenya Y. Popova, Nikki Keasey, Thomas P. Loughran, David F. Claxton, Sergei A. Grigoryev · 2017 · PLoS ONE
RTK-RAS pathway mutation is enriched in myeloid sarcoma
Mihong Choi, Yoon Kyung Jeon, Choong-Hyun Sun, Hongseok Yun, Junshik Hong, Dong‐Yeop Shin, Inho Kim, Sung‐Soo Yoon, Youngil Koh · 2018 · Blood Cancer Journal
Clonal hematopoiesis and preleukemia—Genetics, biology, and clinical implications
Luise Hartmann, Klaus Hans Metzeler · 2019 · Genes Chromosomes and Cancer
Treatment of acute myeloid leukemia in children: A practical perspective
Grace Egan, Yogi Raj Chopra, Stéphanie Mourad, Kuang‐Yueh Chiang, Johann K. Hitzler · 2021 · Pediatric Blood & Cancer
Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
Jan‐Niklas Eckardt, Sebastian Stasik, Christoph Röllig, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Margrit Crysandt, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen et al. · 2023 · Blood Cancer Journal
Individualizing kinase-targeted cancer therapy: the paradigm of chronic myeloid leukemia
Anna M. Eiring, Michael W. Deininger · 2014 · Genome biology
Causes of Chromosomal Instability
Holger Bastians · 2015 · Recent results in cancer research/Recent Results in Cancer Research
Genetic Hierarchy of Acute Myeloid Leukemia: From Clonal Hematopoiesis to Molecular Residual Disease
Jean‐Alain Martignoles, François Delhommeau, Pierre Hirsch · 2018 · International Journal of Molecular Sciences
Currently available bulk sequencing data do not necessarily support a model of neutral tumor evolution
Thomas O. McDonald, Shaon Chakrabarti, Franziska Michor A · 2018 · Nature Genetics
Stem Cell DNA Damage and Genome Mutation in the Context of Aging and Cancer Initiation
Lara Al Zouabi, Allison J. Bardin · 2020 · Cold Spring Harbor Perspectives in Biology
Synthetic lethality and cancer: cohesin and PARP at the replication fork
Nigel J. O’Neil, Derek M. van Pel, Philip Hieter · 2013 · Trends in Genetics
FLT3 Inhibitors in AML: Are We There Yet?
Akshay Sudhindra, Catherine Choy Smith · 2014 · Current Hematologic Malignancy Reports
Attenuated DNA damage responses and increased apoptosis characterize human hematopoietic stem cells exposed to irradiation
Shahar Biechonski, Leonid Olender, Adi Zipin‐Roitman, Muhammad Yassin, Nasma Aqaqe, Victoria Marcu‐Malina, Melanie Rall-Scharpf, Magan Trottier, M. Stephen Meyn, Lisa Wiesmüller et al. · 2018 · Scientific Reports
Clonal Evolution and Changes in Two AML Patients Detected with A Novel Single-Cell DNA Sequencing Platform
Liwen Xu, Robert Durruthy-Durruthy, Dennis J. Eastburn, Maurizio Pellegrino, Omid Shah, Everett H. Meyer, James L. Zehnder · 2019 · Scientific Reports
Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse
Esther Onecha, Inmaculada Rapado, María Luz Morales, Gonzalo Carreño‐Tarragona, Pilar Martínez‐Sánchez, Xabier Gutiérrez, José María Sánchez Pina, María Linares, Miguel Gallardo, Joaquín Martínez‐López et al. · 2020 · Haematologica
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment
Laurène Fenwarth, Élise Fournier, Meyling Hua-Chen Cheok, Thomas Boyer, Fanny Gonzales, Sylvie Castaigné, Nicolas Boissel, Juliette Lambert, Hervé Dombret, Claude Preudhomme et al. · 2020 · International Journal of Molecular Sciences
Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
Sebastian Stasik, Jan‐Niklas Eckardt, Michael Krämer, Christoph Röllig, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Margrit Crysandt, Tim H. Brümmendorf, Ralph Naumann et al. · 2021 · Blood Advances
DNA methylation: a saga of genome maintenance in hematological perspective
Saran Chattopadhyaya, Somnath Ghosal · 2022 · Human Cell
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter
Gregory W. Roloff, Elizabeth A. Griffiths · 2018 · Blood Advances
Chromatin structure in cancer
Meng Wang, Benjamin D. Sunkel, William C. Ray, Benjamin Z. Stanton · 2022 · BMC Molecular and Cell Biology
Cancer in the parasitic protozoans Trypanosoma brucei and Toxoplasma gondii
Zhao‐Rong Lun, De‐Hua Lai, Yan‐Zi Wen, Ling‐Ling Zheng, Ji-Long Shen, Ting-Bo Yang, Wen‐Liang Zhou, Liang‐Hu Qu, Geoff Hide, Francisco Jose Ayala · 2015 · Proceedings of the National Academy of Sciences
The Biology of Aging and Lymphoma: a Complex Interplay
Clémentine Sarkozy, Gilles A. Salles, Claire Falandry · 2015 · Current Oncology Reports
PML Recruits TET2 to Regulate DNA Modification and Cell Proliferation in Response to Chemotherapeutic Agent
Chengli Song, Lina Wang, Xiaoyan Wu, Kai Wang, Dan Xie, Qi Xiao, Songyu Li, Kui Jiang, Lujian Liao, John R. Yates et al. · 2018 · Cancer Research
Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Mia Y. Platt, Amir Tahmasb Fathi, Darrell R. Borger, Andrew Mark Brunner, Robert Paul Hasserjian, Leonora Balaj, Amy M. Lum, Stephen S. F. Yip, Dora C. Dias-Santagata, Zongli Zheng et al. · 2015 · Journal of Molecular Diagnostics
Cohesin and human disease: lessons from mouse models
Vijay Pratap Singh, Jennifer L. Gerton · 2015 · Current Opinion in Cell Biology
Insights into cell ontogeny, age, and acute myeloid leukemia
Shahzya Chaudhury, Jessica Morison, Brenda E. S. Gibson, Karen Keeshan · 2015 · Experimental Hematology
Cornelia de Lange individuals with new and recurrent SMC1A mutations enhance delineation of mutation repertoire and phenotypic spectrum
Cristina Gervasini, Silvia Russo, Anna Cereda, Ilaria Parenti, Maura Masciadri, Jacopo Azzollini, Daniela Melis, Teresa Aravena, Bérénice Doray, Alessandra Ferrarini et al. · 2013 · American Journal of Medical Genetics Part A
Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing
Bianhong Wang, Yangyang Liu, Guangyuan Hou, Lili Wang, Na Lv, Yuanyuan Xu, Yihan Xu, Xiuli Wang, Zhaoling Xuan, Yu Jing et al. · 2016 · Oncotarget
Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective
Tianfang Ma, Fangxia Zou, Stefan Pusch, Yungen Xu, Andreas von Deimling, Xiaoming Zha · 2018 · Journal of Medicinal Chemistry
Remethylation of <i>Dnmt3a</i> <sup>−/−</sup> hematopoietic cells is associated with partial correction of gene dysregulation and reduced myeloid skewing
Ketkar, Shamika, Verdoni, Angela M., Smith, Amanda M., Bangert, Celia V., Leight, Elizabeth R., Chen, David Y., Brune, Meryl K., Helton, Nichole M., Hoock, Mieke, George, Daniel R. et al. · 2020 · Proceedings of the National Academy of Sciences